Aphios Corporation is developing enabling technology platforms for improving drug discovery, manufacturing, delivery and pathogenic safety, and enhanced therapeutics for health maintenance, disease prevention and the treatment of certain infectious diseases, cancers and CNS disorders.
Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins
Aphios, SAIC-Frederick Sign Subcontract to Develop Nanosomal Formulations for Cancer Treatment
Aphios Secures NIA SBIR Grant to Develop Nanodrug for Alzheimer’s Disease
Aphios Receives U.S. Patent to Formulate Polymer Nanospheres
Dr. Jeffrey Dick
In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Dr. Jeffrey Dick about his work studying the chemistry of small volumes and nano-electrochemical tools.
Here, AZoNano speaks with Dirigent Acoustics about the benefits graphene could bring to acoustic and audio technologies and how the company's relationship with the Graphene Flagship has shaped its success.
In this interview, KLA's Bryan Crawford explains everything there is to know about nanoindentation, the challenges that the field currently faces, and how they can be overcome.
The Diamond Interaction Chamber (DIXC) is integral to the NanoGenizer high-pressure homogenizer.
The new AUTOsample-100 mounting autosampler is compatible with the 100 MHz benchtop NMR spectrometer.
The Vistec SB3050-2 is the most advanced electron beam lithography system with variable-shaped beam technology, allowing a wide range of applications in research and development, prototyping, and small-volume production.